J Lévy

1.3k total citations
11 papers, 985 citations indexed

About

J Lévy is a scholar working on Molecular Biology, Genetics and Biochemistry. According to data from OpenAlex, J Lévy has authored 11 papers receiving a total of 985 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 3 papers in Genetics and 3 papers in Biochemistry. Recurrent topics in J Lévy's work include Retinoids in leukemia and cellular processes (3 papers), Antioxidant Activity and Oxidative Stress (3 papers) and Estrogen and related hormone effects (2 papers). J Lévy is often cited by papers focused on Retinoids in leukemia and cellular processes (3 papers), Antioxidant Activity and Oxidative Stress (3 papers) and Estrogen and related hormone effects (2 papers). J Lévy collaborates with scholars based in Israel, United States and Australia. J Lévy's co-authors include Michael Danilenko, Yoav Sharoni, Amit Nahum, Keren Hirsch, Owen W.J. Prall, Colin K. W. Watts, Hadar Amir, Michael Karas, Shraga Segal and Daniel Fishman and has published in prestigious journals such as Brain, Oncogene and British Journal of Anaesthesia.

In The Last Decade

J Lévy

11 papers receiving 928 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
J Lévy Israel	8	604	464	149	120	117	11	985
Vihas T. Vasu United States	21	300 0.5×	372 0.8×	71 0.5×	175 1.5×	63 0.5×	39	1.1k
Vanessa Pitozzi Italy	19	202 0.3×	314 0.7×	171 1.1×	129 1.1×	141 1.2×	30	1000
M. Carmen Crespo Spain	20	183 0.3×	394 0.8×	213 1.4×	195 1.6×	255 2.2×	36	1.1k
Roberto Pizzala Italy	17	203 0.3×	271 0.6×	96 0.6×	103 0.9×	62 0.5×	32	735
Adriana Zamburlini Italy	9	353 0.6×	206 0.4×	194 1.3×	150 1.3×	18 0.2×	10	696
Arumugam Arunkumar India	16	143 0.2×	356 0.8×	68 0.5×	70 0.6×	138 1.2×	20	896
Chieh‐Hsi Wu Taiwan	21	138 0.2×	511 1.1×	46 0.3×	138 1.1×	84 0.7×	41	1.2k
Pei‐Min Chao Taiwan	21	122 0.2×	328 0.7×	83 0.6×	244 2.0×	45 0.4×	44	1.0k
Yuko Muto Japan	12	282 0.5×	266 0.6×	23 0.2×	110 0.9×	37 0.3×	17	834
Rachel B. Shireman United States	14	135 0.2×	191 0.4×	38 0.3×	169 1.4×	71 0.6×	31	676

Countries citing papers authored by J Lévy

Since Specialization

Citations

This map shows the geographic impact of J Lévy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J Lévy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J Lévy more than expected).

Fields of papers citing papers by J Lévy

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J Lévy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J Lévy. The network helps show where J Lévy may publish in the future.

Co-authorship network of co-authors of J Lévy

This figure shows the co-authorship network connecting the top 25 collaborators of J Lévy. A scholar is included among the top collaborators of J Lévy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J Lévy. J Lévy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

11 of 11 papers shown

Masellis, Mario, S.Karen Collinson, Natalie Freeman, et al.. (2016). Dopamine D2 receptor gene variants and response to rasagiline in early Parkinson’s disease: a pharmacogenetic study. Brain. 139(7). 2050–2062. 49 indexed citations

Nahum, Amit, Keren Hirsch, Michael Danilenko, et al.. (2001). Lycopene inhibition of cell cycle progression in breast and endometrial cancer cells is associated with reduction in cyclin D levels and retention of p27Kip1 in the cyclin E–cdk2 complexes. Oncogene. 20(26). 3428–3436. 175 indexed citations

Karas, Michael, Hadar Amir, Daniel Fishman, et al.. (2000). Lycopene Interferes With Cell Cycle Progression and Insulin-Like Growth Factor I Signaling in Mammary Cancer Cells. Nutrition and Cancer. 36(1). 101–111. 242 indexed citations

Huraux, Catherine, et al.. (1996). A.121 Vascular effects of histamine and acetylcholine in human internal mammary artery. British Journal of Anaesthesia. 76. 38–38. 1 indexed citations

Lévy, J, et al.. (1995). Lycopene is a more potent inhibitor of human cancer cell proliferation than either α‐carotene or β‐carotene. Nutrition and Cancer. 24(3). 257–266. 396 indexed citations

Lévy, J, et al.. (1994). Hormone-specific defect in insulin regulation of (Ca2+ + Mg2+)-adenosine triphosphatase activity in kidney membranes from streptozocin non-insulin-dependent diabetic rats. Metabolism. 43(5). 604–613. 22 indexed citations

Nagy, K., et al.. (1990). High-fat feeding induces tissue-specific alteration in proportion of activated insulin receptors in rats. European Journal of Endocrinology. 122(3). 361–368. 32 indexed citations

Zemel, Michael B., et al.. (1990). Impaired calcium metabolism associated with hypertension in Zucker obese rats. Metabolism. 39(7). 704–708. 57 indexed citations

Dunbar, Joseph C., et al.. (1989). Beta cell desensitization to glucose induced by hyperglycemia is augmented by increased calcium. Diabetes Research and Clinical Practice. 7(3). 187–196. 9 indexed citations

10.

Lévy, J, et al.. (1968). [Contribution to the study of central and peripherical cholinergics and anticholinergics. VI. Benactyzine-oxotremorine antagonism].. PubMed. 22(6). 1277–92. 1 indexed citations

11.

Lévy, J, et al.. (1966). [Oxotremorine, pharmacologic reagent for the study of central and peripheral anticholinergic agents].. PubMed. 150(13). 215–8. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact